HRP990341B1 - Process for the preparation of mometasone furoate - Google Patents
Process for the preparation of mometasone furoateInfo
- Publication number
- HRP990341B1 HRP990341B1 HR990341A HRP990341A HRP990341B1 HR P990341 B1 HRP990341 B1 HR P990341B1 HR 990341 A HR990341 A HR 990341A HR P990341 A HRP990341 A HR P990341A HR P990341 B1 HRP990341 B1 HR P990341B1
- Authority
- HR
- Croatia
- Prior art keywords
- preparation
- mometasone furoate
- mometasone
- furoate
- free
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PT102343A PT102343B (pt) | 1999-08-02 | 1999-08-02 | Processo para a preparacao de furoato mometasona |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP990341A2 HRP990341A2 (en) | 2001-04-30 |
HRP990341B1 true HRP990341B1 (en) | 2003-10-31 |
Family
ID=20085881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR990341A HRP990341B1 (en) | 1999-08-02 | 1999-11-05 | Process for the preparation of mometasone furoate |
Country Status (22)
Country | Link |
---|---|
US (1) | US6177560B1 (ko) |
EP (1) | EP1074558B1 (ko) |
JP (1) | JP3746174B2 (ko) |
KR (1) | KR100640066B1 (ko) |
CN (1) | CN1149222C (ko) |
AT (1) | ATE229970T1 (ko) |
AU (1) | AU765592B2 (ko) |
CA (1) | CA2295455C (ko) |
DE (1) | DE69904585T2 (ko) |
DK (1) | DK1074558T3 (ko) |
ES (1) | ES2189354T3 (ko) |
HR (1) | HRP990341B1 (ko) |
HU (1) | HU227494B1 (ko) |
IL (1) | IL133752A (ko) |
NO (1) | NO321154B1 (ko) |
NZ (1) | NZ500555A (ko) |
PL (1) | PL191103B1 (ko) |
PT (1) | PT102343B (ko) |
RU (1) | RU2208616C2 (ko) |
SI (1) | SI1074558T1 (ko) |
UA (1) | UA60333C2 (ko) |
ZA (1) | ZA996758B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
EP1790754A1 (de) * | 2005-11-24 | 2007-05-30 | Siemens Aktiengesellschaft | Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase |
US8021742B2 (en) * | 2006-12-15 | 2011-09-20 | Siemens Energy, Inc. | Impact resistant thermal barrier coating system |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
PL3106149T3 (pl) | 2009-05-29 | 2020-06-01 | Pearl Therapeutics, Inc. | Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy |
PT105139B (pt) * | 2010-06-01 | 2013-01-29 | Hovione Farmaciencia S A | Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos |
ES2712988T5 (es) | 2013-03-15 | 2022-10-21 | Pearl Therapeutics Inc | Métodos y sistemas para acondicionamiento de materiales cristalinos en partículas |
PE20160155A1 (es) | 2013-05-22 | 2016-04-01 | Pearl Therapeutics Inc | Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos |
CN105481933B (zh) * | 2015-12-25 | 2017-09-19 | 山东京卫制药有限公司 | 一种合成糠酸莫米松的方法 |
CN105566437B (zh) * | 2015-12-30 | 2018-07-20 | 山东京卫制药有限公司 | 一种8dm衍生物及利用其合成糠酸莫米松的方法 |
CN107266518B (zh) * | 2016-04-08 | 2021-03-30 | 天津金耀集团有限公司 | 一种糠酸莫米松晶型及其制备方法 |
TW202317079A (zh) | 2021-07-09 | 2023-05-01 | 美商阿斯特捷利康有限責任公司 | 用於氣溶膠遞送之組合物、方法及系統 |
WO2023119093A1 (en) | 2021-12-20 | 2023-06-29 | Astrazeneca Ab | Compositions, methods and systems for aerosol drug delivery |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0057401B1 (en) * | 1981-02-02 | 1984-08-01 | Schering Corporation | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
SK283666B6 (sk) * | 1996-06-28 | 2003-11-04 | Schering Corporation | Spôsob prípravy 17-esterov 9alfa,21-dihalogén-pregnan- 11beta,17alfa-diol-20-ónov |
US5886200A (en) * | 1996-07-01 | 1999-03-23 | Schering Corporation | Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones |
-
1999
- 1999-08-02 NZ NZ500555A patent/NZ500555A/xx not_active IP Right Cessation
- 1999-08-02 PT PT102343A patent/PT102343B/pt unknown
- 1999-10-21 HU HU9903747A patent/HU227494B1/hu unknown
- 1999-10-22 AU AU56024/99A patent/AU765592B2/en not_active Expired
- 1999-10-25 SI SI9930173T patent/SI1074558T1/xx unknown
- 1999-10-25 ES ES99308380T patent/ES2189354T3/es not_active Expired - Lifetime
- 1999-10-25 DE DE69904585T patent/DE69904585T2/de not_active Expired - Lifetime
- 1999-10-25 DK DK99308380T patent/DK1074558T3/da active
- 1999-10-25 AT AT99308380T patent/ATE229970T1/de active
- 1999-10-25 EP EP99308380A patent/EP1074558B1/en not_active Expired - Lifetime
- 1999-10-26 NO NO19995225A patent/NO321154B1/no not_active IP Right Cessation
- 1999-10-27 ZA ZA9906758A patent/ZA996758B/xx unknown
- 1999-11-03 KR KR1019990048285A patent/KR100640066B1/ko active IP Right Grant
- 1999-11-03 RU RU99123183/04A patent/RU2208616C2/ru active
- 1999-11-04 UA UA99116069A patent/UA60333C2/uk unknown
- 1999-11-05 JP JP31523699A patent/JP3746174B2/ja not_active Expired - Lifetime
- 1999-11-05 HR HR990341A patent/HRP990341B1/xx not_active IP Right Cessation
- 1999-11-05 PL PL336452A patent/PL191103B1/pl unknown
- 1999-11-26 CN CNB991243803A patent/CN1149222C/zh not_active Expired - Lifetime
- 1999-12-27 IL IL13375299A patent/IL133752A/en not_active IP Right Cessation
- 1999-12-29 US US09/476,004 patent/US6177560B1/en not_active Expired - Lifetime
-
2000
- 2000-01-14 CA CA002295455A patent/CA2295455C/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6675400A (en) | Software code protection by obscuring its data-driven form | |
PH31610A (en) | Taxol derivatives. | |
HRP990341B1 (en) | Process for the preparation of mometasone furoate | |
EP1401433A4 (en) | CONSTANTLY CONFORMING ANALOGUES AS AGENTS AGAINST DIABETES AND AGAINST OBESITY, AND ASSOCIATED METHOD | |
WO2002032898A3 (de) | Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
HUP0201711A2 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same | |
AU6093296A (en) | Infectious dengue 2 virus pdk-53 as quadravalent vaccine | |
DK0717041T3 (da) | Krystallinske paclitaxel-hydrater | |
MXPA02001891A (es) | Una composicion de vacuna y metodo para utilizacion de la misma. | |
IL108681A0 (en) | Influenza vaccine compositions | |
AU1951495A (en) | Alphavirus rna as carrier for vaccines | |
HK1026146A1 (en) | A universally applicable blood plasma | |
NZ295238A (en) | Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase | |
GB9420114D0 (en) | Substituted cyclic derivatives as novel antidegenerative agents | |
DE4493718T1 (de) | Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon | |
ZA992354B (en) | A formulation of dihydroartemisinin for the control of wide spectrum of malaria and a process for preparing the same. | |
WO1997013776A3 (fr) | Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux | |
AU7773900A (en) | Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds | |
FI945414A0 (fi) | Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi | |
HU9801086D0 (en) | New benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20181005 Year of fee payment: 20 |
|
PB20 | Patent expired after termination of 20 years |
Effective date: 20191105 |